Episode 7 - Science, PhRMA campaign and new discoveries and J&J's R&D productivity stop gap M&A


Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 27, 2018 01:34 (2y ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 210975244 series 2376277
By whatthepharma. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

In this episode, I discuss the new Pfizer campaign around scientists as well as Martin Shkreli's response to the Davos comments. Then we discuss J&J's move to acquire Actelion and more importantly, their decision to spin off the R&D unit to be independent. Near the end, discussion around scientific discoveries in the area of CAR-T treatment of two babies and new findings in breast cancer including drug resistance and passive/backseat genes that manipulate the cancer progression.

11 episodes